These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9682918)

  • 1. Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states.
    Gonick HC; Ding Y; Vaziri ND; Bagrov AY; Fedorova OV
    Clin Exp Hypertens; 1998; 20(5-6):617-27. PubMed ID: 9682918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Endogenous digitalis-like substance and Na-K-ATPase inhibitor in cardiovascular and renal disease].
    Okamoto S
    Nihon Naibunpi Gakkai Zasshi; 1988 Jan; 64(1):39-50. PubMed ID: 2837414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous plasma Na,K-ATPase inhibitory activity and digoxin like immunoreactivity after acute myocardial infarction.
    Bagrov AYa ; Fedorova OV; Maslova MN; Roukoyatkina NI; Ukhanova MV; Zhabko EP
    Cardiovasc Res; 1991 May; 25(5):371-7. PubMed ID: 1649699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marinobufagenin, an endogenous ligand of alpha-1 sodium pump, is a marker of congestive heart failure severity.
    Fridman AI; Matveev SA; Agalakova NI; Fedorova OV; Lakatta EG; Bagrov AY
    J Hypertens; 2002 Jun; 20(6):1189-94. PubMed ID: 12023690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma endogenous digitalis-like factors in healthy individuals and in dialysis-dependent and kidney transplant patients.
    Vasdev S; Johnson E; Longerich L; Prabhakaran VM; Gault MH
    Clin Nephrol; 1987 Apr; 27(4):169-74. PubMed ID: 3034459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma marinobufagenin-like and ouabain-like immunoreactivity during saline volume expansion in anesthetized dogs.
    Bagrov AY; Fedorova OV; Dmitrieva RI; French AW; Anderson DE
    Cardiovasc Res; 1996 Feb; 31(2):296-305. PubMed ID: 8730407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous and exogenous cardiac glycosides and their mechanisms of action.
    Schoner W; Scheiner-Bobis G
    Am J Cardiovasc Drugs; 2007; 7(3):173-89. PubMed ID: 17610345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous digitalis-like factors in hypertension and chronic renal insufficiency.
    Kelly RA; O'Hara DS; Mitch WE; Steinman TI; Goldszer RC; Solomon HS; Smith TW
    Kidney Int; 1986 Nov; 30(5):723-9. PubMed ID: 3023736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma marinobufagenin-like and ouabain-like immunoreactivity in adrenocorticotropin-treated rats.
    Fedorova OV; Anderson DE; Bagrov AY
    Am J Hypertens; 1998 Jul; 11(7):796-802. PubMed ID: 9683040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous Na,K pump ligands are differentially regulated during acute NaCl loading of Dahl rats.
    Fedorova OV; Lakatta EG; Bagrov AY
    Circulation; 2000 Dec; 102(24):3009-14. PubMed ID: 11113054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
    Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
    Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
    Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further biochemical characterization of an Na+ pump inhibitor purified from human urine.
    Crabos M; Grichois ML; Guicheney P; Wainer IW; Cloix JF
    Eur J Biochem; 1987 Jan; 162(1):129-35. PubMed ID: 3028785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous marinobufagenin-like factor in acute plasma volume expansion.
    Fedorova OV; Doris PA; Bagrov AY
    Clin Exp Hypertens; 1998; 20(5-6):581-91. PubMed ID: 9682914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma ouabain-like activity in essential hypertensive patients and in subjects with primary aldosteronism.
    Delva P; Degan M; Capra C; Fallo F; Mantero F; Menegazzi M; Lechi C; Steele A; Lechi A
    Miner Electrolyte Metab; 1989; 15(5):315-20. PubMed ID: 2554104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin-like immunoreactivity, displacement of ouabain and inhibition of Na+/K+ ATPase by four steroids known to be increased in essential hypertension.
    Seccombe DW; Pudek MR; Nowaczynski W; Humphries KH
    Clin Biochem; 1989 Feb; 22(1):17-21. PubMed ID: 2539926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride--dependent hypertension.
    Fedorova OV; Talan MI; Agalakova NI; Lakatta EG; Bagrov AY
    Circulation; 2002 Mar; 105(9):1122-7. PubMed ID: 11877366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
    Bagrov AY; Fedorova OV
    J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do putative endogenous digitalis-like factors have a physiological role?
    Hansen O
    Hypertension; 1994 Nov; 24(5):640-4. PubMed ID: 7960026
    [No Abstract]   [Full Text] [Related]  

  • 20. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia.
    Lopatin DA; Ailamazian EK; Dmitrieva RI; Shpen VM; Fedorova OV; Doris PA; Bagrov AY
    J Hypertens; 1999 Aug; 17(8):1179-87. PubMed ID: 10466474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.